VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients.
Cardiomyopathy
Late enhancement
VT ablation
Wall thinning
inHEART
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
19 Dec 2023
19 Dec 2023
Historique:
received:
07
04
2023
accepted:
09
10
2023
medline:
19
12
2023
pubmed:
19
12
2023
entrez:
19
12
2023
Statut:
aheadofprint
Résumé
The eradication of ventricular tachycardia (VT) isthmus sites constitutes the minimal procedural endpoint for VT ablation procedures. Contemporary high-resolution computed tomography (CT) imaging, in combination with computer-assisted analysis and segmentation of CT data, facilitates targeted elimination of VT isthmi. In this context, inHEART offers digitally rendered three-dimensional (3D) cardiac models which allow preoperative planning for VT ablations in ischemic and non-ischemic cardiomyopathies. To date, almost no data have been collected to compare the outcomes of VT ablations utilizing inHEART with those of traditional ablation approaches. The presented data are derived from a retrospective analysis of n = 108 patients, with one cohort undergoing VT ablation aided by late-enhancement CT and subsequent analysis and segmentation by inHEART, while the other cohort received ablation through conventional methods like substrate mapping and activation mapping. The ablations were executed utilizing a 3D mapping system (Carto3), with the mapping generated via the CARTO® PENTARAY™ NAV catheter and subsequently merged with the inHEART model, if available. Results showed more successful outcome of ablations for the inHEART group with lower VT recurrence (27% vs. 42%, p < 0.06). Subsequent analyses revealed that patients with ischemic cardiomyopathies appeared to derive a significant benefit from inHEART-assisted VT ablation procedures, with a higher rate of successful ablation (p = 0.05). Our findings indicate that inHEART-guided ablation is associated with reduced VT recurrence compared to conventional procedures. This suggests that employing advanced imaging and computational modeling in VT ablation may be valuable for VT recurrences.
Identifiants
pubmed: 38112744
doi: 10.1007/s00392-023-02321-1
pii: 10.1007/s00392-023-02321-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Cronin EM et al (2019) 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace 21(8):1143–1144. https://doi.org/10.1093/europace/euz132
doi: 10.1093/europace/euz132
pubmed: 31075787
pmcid: 7967791
Sapp JL et al (2016) Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 375(2):111–121. https://doi.org/10.1056/NEJMoa1513614
doi: 10.1056/NEJMoa1513614
pubmed: 27149033
Stevenson WG, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD et al (1993) Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 88:1647–1670
doi: 10.1161/01.CIR.88.4.1647
pubmed: 8403311
Sacher F et al (2015) Substrate mapping and ablation for ventricular tachycardia: the LAVA approach. J Cardiovasc Electrophysiol 26(4):464–471. https://doi.org/10.1111/jce.12565
doi: 10.1111/jce.12565
pubmed: 25328104
Berruezo A et al (2015) Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation. Circ Arrhythm Electrophysiol 8(2):326–336. https://doi.org/10.1161/CIRCEP.114.002386
doi: 10.1161/CIRCEP.114.002386
pubmed: 25583983
Di Biase L et al (2015) Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the vista randomized multicenter trial. J Am Coll Cardiol 66(25):2872–2882. https://doi.org/10.1016/j.jacc.2015.10.026
doi: 10.1016/j.jacc.2015.10.026
pubmed: 26718674
Kitamura T et al (2019) Substrate mapping and ablation for ventricular tachycardia in patients with structural heart disease: how to identify ventricular tachycardia substrate. J Innov Card Rhythm Manag 10(3):3565–3580. https://doi.org/10.19102/icrm.2019.100302
doi: 10.19102/icrm.2019.100302
pubmed: 32477720
pmcid: 7252795
Yamashita S et al (2016) Image integration to guide catheter ablation in scar-related ventricular tachycardia. J Cardiovasc Electrophysiol 27(6):699–708. https://doi.org/10.1111/jce.12963
doi: 10.1111/jce.12963
pubmed: 26918883
Esposito A et al (2016) Cardiac CT with delayed enhancement in the characterization of ventricular tachycardia structural substrate: relationship between CT-segmented scar and electro-anatomic mapping. JACC Cardiovasc Imaging 9(7):822–832. https://doi.org/10.1016/j.jcmg.2015.10.024
doi: 10.1016/j.jcmg.2015.10.024
pubmed: 26897692
Ghannam M et al (2018) Correlation between computer tomography-derived scar topography and critical ablation sites in postinfarction ventricular tachycardia. J Cardiovasc Electrophysiol 29(3):438–445. https://doi.org/10.1111/jce.13441
doi: 10.1111/jce.13441
pubmed: 29380921
Komatsu Y et al (2013) Regional myocardial wall thinning at multidetector computed tomography correlates to arrhythmogenic substrate in postinfarction ventricular tachycardia: assessment of structural and electrical substrate. Circ Arrhythm Electrophysiol 6(2):342–350. https://doi.org/10.1161/CIRCEP.112.000191
doi: 10.1161/CIRCEP.112.000191
pubmed: 23476043
Caruso D et al (2016) Dynamic CT myocardial perfusion imaging. Eur J Radiol 85(10):1893–1899. https://doi.org/10.1016/j.ejrad.2016.07.017
doi: 10.1016/j.ejrad.2016.07.017
pubmed: 27510361
Zghaib T et al (2018) Standard ablation versus magnetic resonance imaging-guided ablation in the treatment of ventricular tachycardia. Circ Arrhythm Electrophysiol 11(1):e005973. https://doi.org/10.1161/CIRCEP.117.005973
doi: 10.1161/CIRCEP.117.005973
pubmed: 29330333
pmcid: 5776749
Hutchinson MD et al (2011) Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 4(1):49–55. https://doi.org/10.1161/CIRCEP.110.959957
doi: 10.1161/CIRCEP.110.959957
pubmed: 21131557
Glashan CA et al (2022) Multielectrode unipolar voltage mapping and electrogram morphology to identify post-infarct scar geometry: validation by histology. JACC Clin Electrophysiol 8(4):437–449. https://doi.org/10.1016/j.jacep.2021.11.012
doi: 10.1016/j.jacep.2021.11.012
pubmed: 35450598
Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia (inEurHeart). AI, Digital Twin & Clinical Trial for a Disruption in Catheter Ablation (2023). https://ineurheart.eu/en/